List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 121 studies with search of: Amphotericin B OR Amphocin, Fungizone, AmBisome, Abelecet, Amphotec[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Condition: Leishmaniasis, Visceral
Interventions: Drug: Amphotericin B Lipid emulsion;   Drug: Liposomal Amphotericin B
2 Recruiting Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B;   Drug: liposomal amphotericin B + miltefosine;   Drug: liposomal amphotericin B + paromomycin;   Drug: Miltefosine + Paromomycin
3 Completed
Has Results 		Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Voriconazole;   Drug: Liposomal amphotericin B
4 Completed Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: amphotericin B deoxycholate
5 Completed A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplantation;   Fungus Diseases
Interventions: Drug: caspofungin;   Drug: liposomal amphotericin B
6 Completed Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
Conditions: Lung Transplantation;   Fungal Infections
Intervention: Drug: Amphotericin B
7 Completed Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
Conditions: Lung Transplantation;   Fungal Infections
Intervention: Drug: Amphotericin B
8 Completed A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B fat emulsion in visceral leishmaniasis;   Drug: Amphotericin B fat emulsion;   Drug: Amphotericin B in fat emulsion
9 Terminated Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
Condition: Febrile Neutropenia
Intervention: Drug: Liposomal amphotericin B (AmBisome®)
10 Completed Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
Condition: Visceral Leishmaniasis
Interventions: Drug: Meglumine antimoniate;   Drug: Amphotericin B-deoxycholate
11 Completed A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B
12 Suspended Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
Condition: Candidiasis
Interventions: Drug: micafungin;   Drug: amphotericin B deoxycholate
13 Terminated Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B (Ambisome)
14 Completed Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B and Miltefosine
15 Recruiting Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Condition: Primary Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate;   Drug: Liposomal amphotericin B + miltefosine;   Drug: Miltefosine
16 Terminated Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
Condition: Aspergillosis
Interventions: Drug: Micafungin;   Drug: Liposomal Amphotericin B
17 Active, not recruiting Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment
Condition: Zygomycosis
Intervention: Drug: Liposomal Amphotericin B
18 Completed Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Amphotericin B, Lipid-based;   Drug: Amphotericin B
19 Active, not recruiting Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
Conditions: Invasive Fungal Infections;   Hematologic Malignancies
Interventions: Drug: Posaconazole;   Drug: Amphotericin B Liquid Complex (ABLC)
20 Recruiting Prevention of Invasive Fungal Infections in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
Condition: Invasive Fungal Infection
Interventions: Drug: Liposomal amphotericin B;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services